Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D5T9GZ
|
|||
Drug Name |
CLL1-CD33 cCART cell therapy
|
|||
Drug Type |
CAR T Cell Therapy
|
|||
Indication | Acute myeloid leukaemia [ICD-11: 2A60; ICD-9: 205] | Phase 1 | [1] | |
Company |
iCell Gene Therapeutics
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Myeloid cell surface antigen CD33 (CD33) | Target Info | . | [1] |
Myeloid inhibitory C-type lectin-like receptor (CD371) | Target Info | . | [1] | |
KEGG Pathway | Hematopoietic cell lineage | |||
Reactome | Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
References | Top | |||
---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of iCell Gene Therapeutics. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.